Cutaneous Oncology News

Approvals of BRAF-targeted therapies and immune checkpoint inhibitors have greatly expanded the melanoma treatment landscape during the past decade, according to a speaker at Chemotherapy Foundation Symposium.

A higher rate of metastasis and death occurred in those with cutaneous squamous cell carcinomas with lymphovascular invasion, according to a study.

Lower overall mortality, but not melanoma-specific mortality, was associated with melanoma diagnosed through routine skin checks, according to a study.

Localized Merkel cell carcinoma tumors with a primary site in the neck and scalp were associated with the highest 5-year probability of mortality, according to a study.

The FDA granted fast track designation to UV1 in combination with checkpoint inhibitor therapy for treatment of unresectable or metastatic melanoma.

A novel trichoscopic description of persistent chemotherapy-induced alopecia was reported in a cohort of mostly women with breast cancer, according to a study.

A portable photodynamic therapy device for at-home treatment of basal cell carcinoma was shown to be efficacious in a pilot study presented at the EADV virtual congress.

Klisyri is available for prescription in Germany and the U.K., according to a press release from Almirall.

Surgical delays of 1 year or less were associated with tumor growth in a cohort of patients with squamous cell carcinomas, according to a study.

Prescriptions for opioids following Mohs micrographic surgery have declined in recent years, suggesting patients and surgeons are responding to concerns regarding the opioid epidemic, according to a study.